Share chart Alkem Laboratories Limited
About Alkem Laboratories Limited
Alkem Laboratories Limited, фармацевтическая компания, занимается разработкой, производством и продажей фармацевтической и нутрицевтической продукции в Индии и за рубежом. Компания предлагает фирменные дженерики, дженерики, активные фармацевтические ингредиенты, биоаналоги и нутрицевтики в острых и хронических терапевтических областях, включая противоинфекционную, дерматологическую, сердечную, респираторную, желудочно-кишечную, центральную нервную систему, онкологию, урологию и гинекологию. more details| ISIN | INE540L01014 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 1.69 |
| Дивиденд ао | 42 |
| Сайт | https://www.alkemlabs.com |
| Цена ао | 4706.95 |
| Change price per day: | -0.5428% (4706.95) |
|---|---|
| Change price per week: | -1.2% (4738.05) |
| Change price per month: | -0.5777% (4708.6) |
| Change price per 3 month: | -12.86% (5372.55) |
| Change price per half year: | -26.36% (6357.45) |
| Change price per year: | -7.21% (5045.2) |
| Change price per 3 year: | +38.47% (3380.8) |
| Change price per 5 year: | +95.15% (2398.85) |
| Change price per 10 year: | 0% (4681.4) |
| Change price per year to date: | -14.62% (5482.7) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| FlexShares Emerging Markets Quality Low Volatility Index Fund | 0.21959 | 15.93 | 3.30543 |
| Franklin FTSE India ETF | 0.20562 | 20.52 | 1.25133 |
| Invesco S&P Emerging Markets Momentum ETF | 0.17424 | 18.98 | 2.50979 |
WisdomTree India Earnings Fund
|
0.08302 | 5.23 | 1.65591 |
| Franklin FTSE Asia ex Japan ETF | 0.05195 | 14.43 | 2.66768 |
| PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF | 0.04379 | 2.43 | 4.35382 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.03541 | 12.46 | 3.59676 |
| John Hancock Multifactor Emerging Markets ETF | 0.03519 | 4.68 | 3.42078 |
| WisdomTree Global ex-U.S. Quality Dividend Growth Fund | 0.02896 | 9.11 | 2.73928 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.0157 | 15.96 | 3.34087 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.01096 | 13.06 | 3.62488 |
| Vanguard ESG International Stock ETF | 0.01 | 6.39 | 3.07501 |
| SPDR Portfolio Emerging Markets ETF | 0.00688 | 11.59 | 3.1879 |
| 0.07 | 11.6 | 2.98 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Basudeo Narian Singh | Executive Chairman | 192.5M | 1941 (84 years) |
| Mr. Sandeep Derjit Singh | MD & Executive Director | 82.7M | 1982 (43 years) |
| Mr. Sarvesh Singh | VP of Sales & Marketing and Executive Director | 43.3M | 1981 (44 years) |
| Mr. Mritunjay Kumar Singh | Executive Director | 95.9M | 1963 (62 years) |
| Ms. Madhurima Singh | Executive Director | 94.9M | 1965 (60 years) |
| Mr. Srinivas Singh | Executive Director | 98.91M | 1989 (36 years) |
| Dr. Vikas Gupta | Chief Executive Officer | N/A | |
| Dr. Akhilesh D. Sharma | President & Chief Medical Officer | 1969 (56 years) | |
| Mr. Kaustav Banerjee | President & Head Medtech Business | ||
| Mr. Rajorshi Ganguli | President & Global HR Head | 1971 (54 years) |
Address: India, Mumbai, Alkem House - open in Google maps, open in Yandex maps
Website: https://www.alkemlabs.com
Website: https://www.alkemlabs.com
